| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Carisma Therapeutics Inc.
13G/A
CARM · 14216R101
|
4.4% |
4/25/2025
Event 3/31/2025
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.